Synthesis 2012; 44(14): 2231-2236
DOI: 10.1055/s-0031-1290371
paper
© Georg Thieme Verlag Stuttgart · New York

A Practical Synthesis of 2-{4-[4-Fluoro-3-(trifluoromethyl)phenyl]-2-(piperidin-4-yl)-1H-imidazol-1-yl}-N,N-dimethylethanamine

Radhe K. Vaid*
a   Chemical Product Research and Development, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
,
Jeremy Spitler
a   Chemical Product Research and Development, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
,
Sathish Boini
a   Chemical Product Research and Development, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
,
Kenneth Henry
b   Discovery Chemistry Research and Technologies, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
,
Xu Jiansheng
c   Shanghai PharmaExplorer, Shanghai 20120, P. R. of China, Fax: +1(317)2764507   Email: vaid_radhe_k@lilly.com
,
Baitao Gao
c   Shanghai PharmaExplorer, Shanghai 20120, P. R. of China, Fax: +1(317)2764507   Email: vaid_radhe_k@lilly.com
,
Xiaoquan Lu
c   Shanghai PharmaExplorer, Shanghai 20120, P. R. of China, Fax: +1(317)2764507   Email: vaid_radhe_k@lilly.com
› Author Affiliations
Further Information

Publication History

Received: 16 March 2012

Accepted after revision: 26 April 2012

Publication Date:
13 June 2012 (online)


Abstract

A practical synthesis of the title compound was accomplished by hydrogenation of 2-{4-[4-fluoro-3-(trifluoromethyl)phenyl]-2-(pyridin-4-yl)-1H-imidazol-1-yl}-N,N-dimethylethanamine. The latter was obtained by N-alkylation of 4-{4-[4-fluoro-3-(trifluoromethyl)phenyl]-1H-imidazol-2-yl}pyridine. Treatment of N-{2-[4-fluoro-3-(trifluoromethyl)phenyl]-2-oxoethyl}isonicotinamide hydrochloride with ammonium acetate in acetic acid provided 4-{4-[4-fluoro-3-(trifluoromethyl)phenyl]-1H-imidazol-2-yl}pyridine. Coupling of 2-amino-1-[4-fluoro-3-(trifluoromethyl)phenyl]ethanone 4-methylbenzene sulfonate with pyridine 4-carboxylic acid using either T3P or EDCI-HOBt provided N-{2-[4-fluoro-3-(trifluo­romethyl)phenyl]-2-oxoethyl}isonicotinamide hydrochloride.

 
  • References

  • 1 Fromtling RA. Clin. Microbiol. Rev. 1988; 1: 187
  • 2 Sharpe TR, Cherfolsky SC, Hewes WE, Smith DH, Gregory WA, Haber SB, Leadbetter MR, Whitney JG. J. Med. Chem. 1985; 28: 1188
  • 3 Uçucu Ü, Gündoğdu N, Işikadağ I. Farmaco 2001; 56: 285
  • 4 Graczyk PP, Khan A, Bhatia GS, Palmer V, Medland D, Numata H, Oinuma H, Catchick J, Dunne A, Ellis M, Smales C, Whitfield J, Neame SJ, Sha B, Whilton D, Morgan L, Patel T, Chung R, Desmond D, Staddon JM, Sato N, Inoue A. Bioorg. Med. Chem. Lett. 2005; 15: 4664
  • 5 Laufer SA, Zimmermann W, Ruff J. J. Med. Chem. 2004; 47: 6311
  • 6 Black JW, Durant GI, Emmett JC, Ganellin CR. Nature 1974; 248: 65
  • 7 Srinivas N, Palne S, Nishi Gupta S, Bhandari K. Bioorg. Med. Chem. Lett. 2009; 19: 324
  • 8 Kiselyov AS, Semenova M, Semenov VV. Bioorg. Med. Chem. Lett. 2006; 16: 1440
  • 9 Blum CA, Zheng X, DeLombaert S. J. Med. Chem. 2004; 47: 2318

    • For leading references, see:
    • 10a Jin Z. Nat. Prod. Rep. 2009; 26: 382
    • 10b Jin Z. Nat. Prod. Rep. 2006; 23: 464
    • 10c Jin Z. Nat. Prod. Rep. 2005; 22: 196
    • 10d Cui B, Zheng BL, He K, Zheng QY. J. Nat. Prod. 2003; 66: 1101
  • 11 Shepherd TA, Dally RD, Joseph S. US Patent 120801 A1, 2010
    • 12a Bellina F, Rossi R. Adv. Synth. Catal. 2010; 352: 1 ; and references cited therein
    • 12b Zuliana V, Cocconcelli G, Fantini M, Ghiron C, Rivara M. J. Org. Chem. 2007; 72: 4551
  • 13 Jennings LD, Foreman KW, Rush TS, Tsao DH. H, Mosyak L, Kincaid SL, Sukhdeo MN, Sutherland AG, Ding W, Kenny CH, Sabus CL, Liu H, Dushhin EG, Moghazeh SL, Labthavikul P, Peterse PJ, Tuckman M, Ruzin AV. Bioorg. Med. Chem. 2004; 12: 5115
  • 14 Phillips JG, Jaworska M, Lew W. Synthesis 2010; 71